The medication for the treatment of intestinal infections

Consumers survey results of 2018 in category

Digestive system and hepatology / The medication for the treatment of intestinal infections

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Atoxil (Orisil-Pharm)	35.21%	5

2.	3	Нифуроксазид (Gedeon Richter)	32.39%	4.64

3.	5	Ентерол (Біокодекс Україна)	21.13%	3.23

4.	2	Фталазол (Darnitsa)	21.13%	3.21

5.	7	Нифуроксазид (Ternopharm)	19.72%	2.80

6.	4	Фталазол (Lab. Ofichem)	12.68%	1.81

7.	9	Фталазол-КМП (Arterium Corporation)	6.34%	1.10

8.	6	Фталазол-Здоров’я (Pharmaceutical company “Zdorovya”)	6.34%	1.09

–.	8	~~Ентобан (Herbion)~~	~~1.41%~~	~~0.36~~

9.		Буларді МАКС (Delta Medical)	2.11%	0.25

The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2018 in the “The drug for the treatment of intestinal infections” category!

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2018, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.